NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN – Get Free Report) has earned a consensus recommendation of “Hold” from the seven ratings firms that are currently covering the stock, MarketBeat reports. Five investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1-year target price among analysts that have covered the stock in the last year is C$6.46.
A number of research firms have recently commented on NWH.UN. National Bankshares raised their target price on NorthWest Health Prop Real Est Inv Trust from C$5.25 to C$5.75 and gave the company a “sector perform” rating in a research report on Thursday, May 16th. BMO Capital Markets upped their target price on NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$5.25 and gave the stock a “market perform” rating in a research note on Monday, May 27th. Finally, CIBC lifted their price target on shares of NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$5.75 and gave the company a “neutral” rating in a research note on Thursday, May 16th.
View Our Latest Research Report on NorthWest Health Prop Real Est Inv Trust
NorthWest Health Prop Real Est Inv Trust Price Performance
About NorthWest Health Prop Real Est Inv Trust
NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.
Featured Stories
- Five stocks we like better than NorthWest Health Prop Real Est Inv Trust
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- MarketBeat Week in Review – 8/5 – 8/9
- Stock Sentiment Analysis: How it Works
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- Why Invest in 5G? How to Invest in 5G Stocks
- The Cannabis Sector: Profitability Takes Center Stage
Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.